Exclusive

Publication

Byline

Location

US Patent Issued to Takeda Pharmaceutical on May 12 for "Treatment of patients with severe von Willebrand disease undergoing elective surgery by administration of recombinant VWF" (Austrian, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,950, issued on May 12, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Treatment of patients with severe von Willebrand dise... Read More


US Patent Issued to ProAbtech on May 12 for "Urate oxidase-albumin conjugate, preparation method thereof, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,951, issued on May 12, was assigned to ProAbtech Co. LTD. (Gwangju, South Korea). "Urate oxidase-albumin conjugate, preparation method there... Read More


US Patent Issued to Amicus Therapeutics on May 12 for "Formulations comprising recombinant acid Alpha-glucosidase" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,952, issued on May 12, was assigned to Amicus Therapeutics Inc. (Philadelphia). "Formulations comprising recombinant acid Alpha-glucosidase"... Read More


US Patent Issued to Evaxion, Statens Serum Institut on May 12 for "Vaccines targeting neoepitopes" (Danish Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,953, issued on May 12, was assigned to Evaxion A/S (Horsholm, Denmark) and Statens Serum Institut (Copenhagen S., Denmark). "Vaccines target... Read More


US Patent Issued to Bristol-Myers Squibb on May 12 for "Anti-ICOS agonist antibodies and uses thereof" (California, Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,954, issued on May 12, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Anti-ICOS agonist antibodies and uses thereof" was inven... Read More


US Patent Issued to EvviVax on May 12 for "Consensus sequence of the antigen telomerase and the use thereof in preventive and therapeutic vaccination" (Italian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,955, issued on May 12, was assigned to EvviVax S.r.l. (Rome). "Consensus sequence of the antigen telomerase and the use thereof in preventiv... Read More


US Patent Issued to Mayo Foundation for Medical Education and Research;, University of Washington on May 12 for "Methods and vaccines for inducing immune responses to multiple different MHC molecules" (Arizona, Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,956, issued on May 12, was assigned to Mayo Foundation for Medical Education and Research; (Rochester) and University of Washington (Seattle)... Read More


US Patent Issued to University of Connecticut on May 12 for "Mycoplasma vaccine composition and methods" (Connecticut Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,957, issued on May 12, was assigned to University of Connecticut (Farmington, Conn.). "Mycoplasma vaccine composition and methods" was inven... Read More


US Patent Issued to University-Industry Cooperation Group of Kyung Hee University on May 12 for "Virus-like particles containing RSV antigen protein and vaccines using the same" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,958, issued on May 12, was assigned to University-Industry Cooperation Group of Kyung Hee University (Yongin-si, South Korea). "Virus-like p... Read More


US Patent Issued to CELLID on May 12 for "Coronavirus recombinant spike protein, polynucleotide encoding same, vector comprising polynucleotide, and vaccine for preventing or treating coronavirus infection, comprising vector" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,959, issued on May 12, was assigned to CELLID Co. LTD. (Seoul, South Korea). "Coronavirus recombinant spike protein, polynucleotide encoding... Read More